Literature DB >> 28528190

Association between the time to surgery and survival among patients with colon cancer: A population-based study.

J A Flemming1, S Nanji2, X Wei3, C Webber4, P Groome4, C M Booth5.   

Abstract

Factors associated with time-to-surgery (TTS) and survival in colon cancer has not been well studied. Cancer Care Ontario recommends surgery within 42 days of diagnosis and that 90% of patients meet this benchmark. We describe factors associated with TTS and survival in routine clinical practice.
METHODS: Retrospective population-based cohort study of patients receiving elective colonic resection after diagnosis of colon cancer in Ontario, Canada from 2002 to 2008 followed until 2012. Factors associated with TTS were identified using multivariate log-binomial and Quantile regression at 42 days and 90th percentiles. The association between TTS and cancer-specific (CSS) and overall survival (OS) were examined using multivariate Cox regression.
RESULTS: 4326 patients; median age 71 years and 52% male. Median TTS was 24 days (IQR 14-37); at the 90th percentile 56 days. Factors associated with TTS ≥ 42 days and >90th percentile included older age, co-morbid illness, surgeon volume, and stage I disease (P < 0.05 for all). In patients whose TTS was either at 42 days or 90th percentile, those ≥80 years old waited two weeks longer than those <60 years, individuals with co-morbid illness waited 10 days longer than without co-morbidity, and patients with stage I disease waited 10 days longer than those with stage IV disease (P < 0.05 for all). Delay in TTS > 42 days or >90th percentile was not associated with OS or CSS.
CONCLUSION: Age, co-morbidity, and stage of cancer are associated with TTS. There was no association between TTS and CSS or OS.
Copyright © 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Cancer-specific survival; Institute for Clinical Evaluative Sciences; Ontario Cancer Registry; Overall survival; Time-to-surgery

Mesh:

Year:  2017        PMID: 28528190     DOI: 10.1016/j.ejso.2017.04.014

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  12 in total

1.  The Impact of Delays to Definitive Surgical Care on Survival in Colorectal Cancer Patients.

Authors:  Maude Trepanier; Tiffany Paradis; Araz Kouyoumdjian; Teodora Dumitra; Patrick Charlebois; Barry S Stein; A Sender Liberman; Kevin Schwartzman; Franco Carli; Gerald M Fried; Liane S Feldman; Lawrence Lee
Journal:  J Gastrointest Surg       Date:  2019-07-31       Impact factor: 3.452

Review 2.  Conflicting Guidelines: A Systematic Review on the Proper Interval for Colorectal Cancer Treatment.

Authors:  Charlotte J L Molenaar; Loes Janssen; Donald L van der Peet; Desmond C Winter; Rudi M H Roumen; Gerrit D Slooter
Journal:  World J Surg       Date:  2021-04-03       Impact factor: 3.352

3.  Evaluating potential delays and outcomes of patients undergoing surgical resection for locally advanced and recurrent colorectal cancer during a pandemic.

Authors:  M A Javed; A Kohler; J Tiernan; A Quyn; P Sagar
Journal:  Ann R Coll Surg Engl       Date:  2022-02-08       Impact factor: 1.951

4.  Relationship Between the Waiting Times for Surgery and Survival in Patients with Gastric Cancer.

Authors:  Yuta Kumazu; Koji Oba; Tsutomu Hayashi; Takanobu Yamada; Kentaro Hara; Hiroaki Osakabe; Yota Shimoda; Masato Nakazono; Shinsuke Nagasawa; Yasushi Rino; Munetaka Masuda; Takashi Ogata; Takaki Yoshikawa; Takashi Oshima
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

Review 5.  Delay to elective colorectal cancer surgery and implications for survival: a systematic review and meta-analysis.

Authors:  Thomas M Whittaker; Mohamed E G Abdelrazek; Aran J Fitzpatrick; Joseph L J Froud; Jack R Kelly; Jeremy S Williamson; Gethin L Williams
Journal:  Colorectal Dis       Date:  2021-03-25       Impact factor: 3.917

6.  What's the magic number? Impact of time to initiation of treatment for rectal cancer.

Authors:  Gretchen C Edwards; Adriana C Gamboa; Michael P Feng; Roberta L Muldoon; Michael B Hopkins; Sherif Abdel-Misih; Glen C Balch; Jennifer Holder-Murray; Maryam Mohammed; Scott E Regenbogen; Matthew L Silviera; Alexander T Hawkins
Journal:  Surgery       Date:  2021-09-24       Impact factor: 4.348

7.  Gastrointestinal Malignancies and the COVID-19 Pandemic: Evidence-Based Triage to Surgery.

Authors:  Scott C Fligor; Sophie Wang; Benjamin G Allar; Savas T Tsikis; Ana Sofia Ore; Ashlyn E Whitlock; Rodrigo Calvillo-Ortiz; Kevin R Arndt; Sidhu P Gangadharan; Mark P Callery
Journal:  J Gastrointest Surg       Date:  2020-06-30       Impact factor: 3.452

8.  Multimorbidity by Patient and Tumor Factors and Time-to-Surgery Among Colorectal Cancer Patients in Spain: A Population-Based Study.

Authors:  Miguel Angel Luque-Fernandez; Daniel Redondo-Sanchez; Shing Fung Lee; Miguel Rodríguez-Barranco; Ma Carmen Carmona-García; Rafael Marcos-Gragera; María-José Sánchez
Journal:  Clin Epidemiol       Date:  2020-01-14       Impact factor: 4.790

9.  The Variations in Care and Real-world Outcomes in Individuals With Rectal Cancer: Protocol for the Ontario Rectal Cancer Cohort.

Authors:  Sunil Patel; Chad McClintock; Christopher Booth; Shaila Merchant; Carl Heneghan; Clare Bankhead
Journal:  JMIR Res Protoc       Date:  2022-08-05

10.  Mortality due to cancer treatment delay: systematic review and meta-analysis.

Authors:  Timothy P Hanna; Will D King; Stephane Thibodeau; Matthew Jalink; Gregory A Paulin; Elizabeth Harvey-Jones; Dylan E O'Sullivan; Christopher M Booth; Richard Sullivan; Ajay Aggarwal
Journal:  BMJ       Date:  2020-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.